209 related articles for article (PubMed ID: 33459165)
21. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
22. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
Lee HS; Suh JY; Kang BC; Lee E
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
[TBL] [Abstract][Full Text] [Related]
23. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
24. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
[TBL] [Abstract][Full Text] [Related]
25. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
26. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
[TBL] [Abstract][Full Text] [Related]
27. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
28. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
Huang F; Sheng XX; Zhang HJ
Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
[TBL] [Abstract][Full Text] [Related]
29. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
[TBL] [Abstract][Full Text] [Related]
30. AMPK signalling: Implications for podocyte biology in diabetic nephropathy.
Szrejder M; Piwkowska A
Biol Cell; 2019 May; 111(5):109-120. PubMed ID: 30702162
[TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
[TBL] [Abstract][Full Text] [Related]
32. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.
Hua P; Feng W; Ji S; Raij L; Jaimes EA
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F732-9. PubMed ID: 20685820
[TBL] [Abstract][Full Text] [Related]
33. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.
Li J; Sun YBY; Chen W; Fan J; Li S; Qu X; Chen Q; Chen R; Zhu D; Zhang J; Wu Z; Chi H; Crawford S; Oorschot V; Puelles VG; Kerr PG; Ren Y; Nilsson SK; Christian M; Tang H; Chen W; Bertram JF; Nikolic-Paterson DJ; Yu X
EMBO Rep; 2020 Feb; 21(2):e48781. PubMed ID: 31916354
[TBL] [Abstract][Full Text] [Related]
34. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
35. ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte.
Yuan S; Liang X; He W; Liang M; Jin J; He Q
Ren Fail; 2021 Dec; 43(1):968-979. PubMed ID: 34157937
[TBL] [Abstract][Full Text] [Related]
36. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.
Cheng H; Fan X; Moeckel GW; Harris RC
J Am Soc Nephrol; 2011 Jul; 22(7):1240-51. PubMed ID: 21737546
[TBL] [Abstract][Full Text] [Related]
37. Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
Chang TT; Chen YA; Li SY; Chen JW
J Ethnopharmacol; 2021 Feb; 266():113474. PubMed ID: 33068650
[TBL] [Abstract][Full Text] [Related]
38. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
[TBL] [Abstract][Full Text] [Related]
40. Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions.
Szrejder M; Rachubik P; Rogacka D; Audzeyenka I; Rychłowski M; Kreft E; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165610. PubMed ID: 31778750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
